Michael Grosso

6.2k total citations · 1 hit paper
96 papers, 3.5k citations indexed

About

Michael Grosso is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Michael Grosso has authored 96 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 32 papers in Internal Medicine and 15 papers in Surgery. Recurrent topics in Michael Grosso's work include Venous Thromboembolism Diagnosis and Management (32 papers), Atrial Fibrillation Management and Outcomes (26 papers) and Cardiac Arrhythmias and Treatments (17 papers). Michael Grosso is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (32 papers), Atrial Fibrillation Management and Outcomes (26 papers) and Cardiac Arrhythmias and Treatments (17 papers). Michael Grosso collaborates with scholars based in United States, Netherlands and Canada. Michael Grosso's co-authors include Alden H. Harken, Michele Mercuri, John E. Repine, Janet M. Brown, Lance S. Terada, Harry R. Büller, George Zhang, Anirban Banerjee, Gary E. Raskob and Peter Verhamme and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Michael Grosso

90 papers receiving 3.3k citations

Hit Papers

Edoxaban for the Treatment of Cancer-Associated Venous Th... 2017 2026 2020 2023 2017 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Grosso United States 27 1.9k 1.6k 595 438 355 96 3.5k
Brian J. O’Neil United States 30 948 0.5× 396 0.2× 465 0.8× 120 0.3× 111 0.3× 90 4.0k
Patrick Henry France 30 2.1k 1.1× 309 0.2× 1.2k 2.0× 541 1.2× 25 0.1× 131 3.9k
Matti Tarkka Finland 31 1.6k 0.8× 225 0.1× 1.3k 2.2× 645 1.5× 45 0.1× 166 3.6k
Marianne Canonico France 27 622 0.3× 564 0.4× 237 0.4× 487 1.1× 55 0.2× 75 3.6k
Jeffrey Lefkovits Australia 23 2.6k 1.3× 289 0.2× 1.1k 1.9× 47 0.1× 57 0.2× 138 3.5k
Maria Boddi Italy 31 1.3k 0.7× 179 0.1× 410 0.7× 127 0.3× 46 0.1× 102 2.6k
Thomas Philipp Germany 38 2.0k 1.0× 259 0.2× 1.7k 2.8× 167 0.4× 23 0.1× 178 6.1k
Vijay Kunadian United Kingdom 31 2.3k 1.2× 129 0.1× 962 1.6× 198 0.5× 32 0.1× 139 3.9k
John Imeson United Kingdom 32 999 0.5× 339 0.2× 925 1.6× 458 1.0× 42 0.1× 48 5.1k
Jean G. Diodati Canada 29 2.5k 1.3× 548 0.3× 845 1.4× 84 0.2× 11 0.0× 76 3.3k

Countries citing papers authored by Michael Grosso

Since Specialization
Citations

This map shows the geographic impact of Michael Grosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Grosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Grosso more than expected).

Fields of papers citing papers by Michael Grosso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Grosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Grosso. The network helps show where Michael Grosso may publish in the future.

Co-authorship network of co-authors of Michael Grosso

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Grosso. A scholar is included among the top collaborators of Michael Grosso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Grosso. Michael Grosso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takada, Toshihiko, Floris T.M. Bosch, Andrea Marshall, et al.. (2024). Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction Model. Thrombosis and Haemostasis. 125(6). 589–596. 2 indexed citations
2.
Bonaca, Marc P., Elliott M. Antman, Jonathan W. Cunningham, et al.. (2021). Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48. European Heart Journal - Cardiovascular Pharmacotherapy. 8(7). 695–706. 4 indexed citations
3.
Oyama, Kazuma, Robert P. Giugliano, David D. Berg, et al.. (2021). Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. European Heart Journal. 42(17). 1698–1706. 23 indexed citations
4.
Bosch, Floris T.M., Frits I. Mulder, Menno V. Huisman, et al.. (2021). Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban. Journal of Thrombosis and Haemostasis. 19(12). 3008–3017. 12 indexed citations
5.
Ommen, C. Heleen van, Manuela Albisetti, Anthony K.C. Chan, et al.. (2020). The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease. Research and Practice in Thrombosis and Haemostasis. 4(5). 886–892. 24 indexed citations
6.
Mulder, Frits I., Marcello Di Nisio, Cihan Ay, et al.. (2019). Clinical implications of incidental venous thromboembolism in cancer patients. European Respiratory Journal. 55(2). 1901697–1901697. 31 indexed citations
7.
Brekelmans, Marjolein, Walter Ageno, Ludo F.M. Beenen, et al.. (2016). Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. The Lancet Haematology. 3(9). e437–e445. 25 indexed citations
8.
Goette, Andreas, José Luís Merino, Michael D. Ezekowitz, et al.. (2016). Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. The Lancet. 388(10055). 1995–2003. 177 indexed citations
9.
Ansell, Jack, Sasha Bakhru, Bryan Laulicht, et al.. (2016). Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban. Thrombosis and Haemostasis. 117(2). 238–245. 104 indexed citations
10.
Mani, Venkatesh, Sarayu Ramachandran, Philip M. Robson, et al.. (2015). A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis. Journal of Visualized Experiments. e52761–e52761. 3 indexed citations
11.
Kelly, Edward F., Emily Williams Kelly, Adam Crabtree, et al.. (2006). Irreducible Mind. 1 indexed citations
12.
Grosso, Michael. (2001). Afterlife Research and the Shamanic Turn. University of North Texas Digital Library (University of North Texas). 20(1). 5–14.
13.
Flum, David R., Aurel C. Cernaianu, Riad Meada, et al.. (1996). Descending thoracic aortomyoplasty: A technique for clinical application. The Annals of Thoracic Surgery. 61(1). 93–98. 7 indexed citations
14.
Cernaianu, Aurel C., et al.. (1995). Latissimus dorsi and serratus anterior dynamic descending aortomyoplasty for ischemic cardiac failure. The Annals of Thoracic Surgery. 59(3). 639–643. 9 indexed citations
15.
Grosso, Michael, James M. Brown, Ernest E. Moore, & Frederick A. Moore. (1991). Repair of the Torn Descending Thoracic Aorta Using the Centrifugal Pump with Partial Left Heart Bypass. The Journal of Trauma: Injury, Infection, and Critical Care. 31(3). 395–400. 9 indexed citations
16.
Grosso, Michael & Alden H. Harken. (1990). Surgical treatment of cardiac arrhythmias. Current Opinion in Cardiology. 5(1). 106–110. 1 indexed citations
17.
Grosso, Michael, Anirban Banerjee, Jared M. Brown, et al.. (1989). Neonatal functional tolerance to ischemia-reperfusion may be induced in adult myocardium by 5'-nucleotidase inhibition. 40. 271–273. 2 indexed citations
18.
Grosso, Michael, James Brown, D. Mulvin, et al.. (1989). Xanthine oxidase-derived oxygen radicals induce pulmonary edema via direct endothelial cell injury. Journal of Surgical Research. 46(4). 355–360. 53 indexed citations
19.
Brown, James M., Michael Grosso, Michael J. Reiter, et al.. (1988). Chronic supraventricular tachycardia can cause severe ventricular dysfunction, which can be surgically repaired. Journal of Thoracic and Cardiovascular Surgery. 96(5). 796–799. 4 indexed citations
20.
Grosso, Michael. (1976). Some varieties of out-of-body experience.. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026